Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
CNY 7.36
(-0.14%)
CNY 7.36
(-0.14%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 476.36 Million CNY | 7.4% |
| 2022 | 443.54 Million CNY | 6.83% |
| 2021 | 415.18 Million CNY | -0.66% |
| 2020 | 417.95 Million CNY | 42.64% |
| 2019 | 293.02 Million CNY | -33.53% |
| 2018 | 440.85 Million CNY | -18.55% |
| 2017 | 541.23 Million CNY | -23.94% |
| 2016 | 711.61 Million CNY | -6.61% |
| 2015 | 761.99 Million CNY | 57.97% |
| 2014 | 482.37 Million CNY | 369.46% |
| 2013 | 102.75 Million CNY | 2548.2% |
| 2012 | 3.88 Million CNY | -22.55% |
| 2011 | 5.01 Million CNY | -88.59% |
| 2010 | 43.89 Million CNY | 56.64% |
| 2009 | 28.02 Million CNY | -64.87% |
| 2008 | 79.77 Million CNY | 1.27% |
| 2007 | 78.77 Million CNY | 17.97% |
| 2006 | 66.77 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 477.06 Million CNY | 0.33% |
| 2024 Q3 | 470.36 Million CNY | -0.61% |
| 2024 Q1 | 475.47 Million CNY | -0.19% |
| 2023 Q3 | 480.79 Million CNY | -0.09% |
| 2023 Q1 | 481.26 Million CNY | 8.5% |
| 2023 FY | 476.36 Million CNY | 7.4% |
| 2023 Q4 | 476.36 Million CNY | -0.92% |
| 2023 Q2 | 481.2 Million CNY | -0.01% |
| 2022 Q3 | 443.34 Million CNY | 7.2% |
| 2022 Q1 | 415.26 Million CNY | 0.02% |
| 2022 Q4 | 443.54 Million CNY | 0.05% |
| 2022 FY | 443.54 Million CNY | 6.83% |
| 2022 Q2 | 413.55 Million CNY | -0.41% |
| 2021 Q1 | 437.97 Million CNY | 4.79% |
| 2021 Q2 | 312.73 Million CNY | -28.59% |
| 2021 Q3 | 400.26 Million CNY | 27.99% |
| 2021 FY | 415.18 Million CNY | -0.66% |
| 2021 Q4 | 415.18 Million CNY | 3.73% |
| 2020 Q1 | 293.02 Million CNY | 0.0% |
| 2020 Q2 | 288.02 Million CNY | -1.71% |
| 2020 Q3 | 418.02 Million CNY | 45.14% |
| 2020 Q4 | 417.95 Million CNY | -0.02% |
| 2020 FY | 417.95 Million CNY | 42.64% |
| 2019 Q2 | 370.85 Million CNY | -15.88% |
| 2019 Q1 | 440.85 Million CNY | 0.0% |
| 2019 FY | 293.02 Million CNY | -33.53% |
| 2019 Q3 | 363.4 Million CNY | -2.01% |
| 2019 Q4 | 293.02 Million CNY | -19.37% |
| 2018 Q1 | 541.23 Million CNY | 0.0% |
| 2018 FY | 440.85 Million CNY | -18.55% |
| 2018 Q4 | 440.85 Million CNY | -12.05% |
| 2018 Q3 | 501.23 Million CNY | 2.04% |
| 2018 Q2 | 491.23 Million CNY | -9.24% |
| 2017 Q2 | 611.61 Million CNY | -10.27% |
| 2017 Q3 | 601.61 Million CNY | -1.64% |
| 2017 Q4 | 541.23 Million CNY | -10.04% |
| 2017 FY | 541.23 Million CNY | -23.94% |
| 2017 Q1 | 681.61 Million CNY | -4.22% |
| 2016 Q4 | 711.61 Million CNY | -2.78% |
| 2016 Q3 | 731.99 Million CNY | -2.66% |
| 2016 Q2 | 751.99 Million CNY | -6.23% |
| 2016 FY | 711.61 Million CNY | -6.61% |
| 2016 Q1 | 801.99 Million CNY | 5.25% |
| 2015 FY | 761.99 Million CNY | 57.97% |
| 2015 Q2 | 792.37 Million CNY | 0.0% |
| 2015 Q1 | 792.37 Million CNY | 64.27% |
| 2015 Q4 | 761.99 Million CNY | -0.06% |
| 2015 Q3 | 762.47 Million CNY | -3.77% |
| 2014 Q3 | 262.75 Million CNY | 0.0% |
| 2014 Q1 | 162.75 Million CNY | 58.39% |
| 2014 FY | 482.37 Million CNY | 369.46% |
| 2014 Q4 | 482.37 Million CNY | 83.59% |
| 2014 Q2 | 262.75 Million CNY | 61.44% |
| 2013 Q3 | 3.88 Million CNY | 0.0% |
| 2013 Q2 | 3.88 Million CNY | 0.0% |
| 2013 Q1 | 3.88 Million CNY | 0.0% |
| 2013 FY | 102.75 Million CNY | 2548.2% |
| 2013 Q4 | 102.75 Million CNY | 2548.2% |
| 2012 Q4 | 3.88 Million CNY | -22.55% |
| 2012 Q3 | 5.01 Million CNY | 0.0% |
| 2012 Q2 | 5.01 Million CNY | 0.0% |
| 2012 Q1 | 5.01 Million CNY | 0.0% |
| 2012 FY | 3.88 Million CNY | -22.55% |
| 2011 Q3 | 3.89 Million CNY | 0.0% |
| 2011 FY | 5.01 Million CNY | -88.59% |
| 2011 Q2 | 3.89 Million CNY | -86.99% |
| 2011 Q1 | 29.89 Million CNY | -31.9% |
| 2011 Q4 | 5.01 Million CNY | 28.79% |
| 2010 Q4 | 43.89 Million CNY | 0.0% |
| 2010 FY | 43.89 Million CNY | 56.64% |
| 2009 FY | 28.02 Million CNY | -64.87% |
| 2009 Q2 | 79.77 Million CNY | 0.0% |
| 2009 Q4 | 28.02 Million CNY | 0.0% |
| 2008 FY | 79.77 Million CNY | 1.27% |
| 2007 FY | 78.77 Million CNY | 17.97% |
| 2006 FY | 66.77 Million CNY | 0.0% |